Elixinol Wellness Limited ELLXF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 4.96% | 0.54% | -4.11% | 8.90% | 27.85% |
| Total Other Revenue | -202.74% | -205.56% | -- | -- | -- |
| Total Revenue | 4.80% | 0.38% | -4.26% | 8.81% | 27.85% |
| Cost of Revenue | -6.57% | -4.67% | -3.16% | 10.42% | 29.82% |
| Gross Profit | 26.90% | 9.80% | -6.24% | 5.89% | 24.17% |
| SG&A Expenses | -2.99% | -0.78% | 0.91% | -1.22% | -1.98% |
| Depreciation & Amortization | -24.40% | -21.28% | -18.71% | -4.06% | 15.18% |
| Other Operating Expenses | -134.87% | -116.02% | -91.20% | 67.15% | 936.00% |
| Total Operating Expenses | -10.59% | -7.36% | -4.57% | 4.85% | 17.66% |
| Operating Income | 53.33% | 29.57% | 5.46% | 5.09% | 3.65% |
| Income Before Tax | 26.53% | 8.86% | -8.27% | 8.72% | 21.00% |
| Income Tax Expenses | 85.22% | 85.22% | 85.22% | -11.89% | -197,800.00% |
| Earnings from Continuing Operations | -91.36% | -149.02% | -204.31% | 17.54% | 73.75% |
| Earnings from Discontinued Operations | 28.63% | -73.38% | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -82.32% | -146.02% | -212.83% | 14.11% | 71.61% |
| EBIT | 53.33% | 29.57% | 5.46% | 5.09% | 3.65% |
| EBITDA | 62.42% | 37.15% | 11.04% | 6.75% | 1.58% |
| EPS Basic | -38.46% | -35.00% | -31.19% | 68.28% | 89.82% |
| Normalized Basic EPS | 64.35% | 49.23% | 36.55% | 47.72% | 53.63% |
| EPS Diluted | -38.46% | -35.00% | -31.19% | 68.39% | 89.86% |
| Normalized Diluted EPS | 64.35% | 49.23% | 36.55% | 47.72% | 53.63% |
| Average Basic Shares Outstanding | 73.24% | 70.01% | 65.77% | 81.14% | 105.12% |
| Average Diluted Shares Outstanding | 73.24% | 70.01% | 65.77% | 81.14% | 105.12% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |